Pricing Log in Create free account

MBody AI Ltd. (MBAI) vs MDxHealth SA (MDXH)

MBody AI Ltd. and MDxHealth SA are both Diagnostics & Research companies. MDxHealth SA is the larger, with a market value of $57.6M against $47.4M — 1.2× the size. MBody AI Ltd. has the higher net margin (0.00% vs −32.5%) and the higher return on invested capital (0.00% vs −23.8%). Across the 13 metrics below, MDxHealth SA leads on 7 and MBody AI Ltd. on 6.

Valuation

Metric MBAI MDXH Diagnostics & Research median
P/E n/m n/m 35.56
P/S n/m 0.10 4.37
P/B 0.61 n/m 3.06
Price to free cash flow n/m n/m 35.76
EV/EBITDA n/m n/m 24.35
EV/Sales n/m 0.84 5.51
Earnings yield (763.41%) (342.86%) (1.89%)
Free cash flow yield (565.34%) (63.49%) (0.15%)

Profitability

Metric MBAI MDXH Diagnostics & Research median
Gross margin 0.00% 63.23% 50.89%
Operating margin 0.00% (18.04%) (8.57%)
Net margin 0.00% (32.53%) (6.37%)
Free cash flow margin 0.00% (5.24%) 0.00%
Return on equity 0.00% 238.67% (2.92%)
Return on assets 0.00% (27.38%) (6.71%)
Return on invested capital 0.00% (23.77%) 0.00%

Growth

Metric MBAI MDXH Diagnostics & Research median
Revenue growth (TTM) — 21.46% 7.69%
EPS growth (last fiscal year) 115.35% 42.24% 25.92%
Revenue growth, 5-year CAGR — 42.34% 7.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MBAI MDXH Diagnostics & Research median
Debt to equity 0.00 (3.42) 0.11
Current ratio 0.71 1.15 2.02
Net debt to EBITDA 0.09 (10.71) 0.70

Dividend

Metric MBAI MDXH Diagnostics & Research median
Dividend yield — — 0.66%
Payout ratio — — 0.20

Size

Metric MBAI MDXH Diagnostics & Research median
Market cap 47.41m 57.60m 2.16b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack